AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $19.94
- 52-wk high
- $34.28
- High
- $20.02
- 52-wk low
- $18.52
- Low
- $18.86
- Prev close
- $19.98
- Mkt cap
- $1.15B
- Volume
- 1.88M
- Fwd P/E
- 4.7x
- Beta
- 1.43
- P/S
- 0.5x
- P/B
- 0.7x
- Profit margin
- -48.0%
- Op margin
- +4.2%
- ROE
- -54.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings came in 3.8% below what analysts expected.
Earnings per share
$0.79 expected
What the street expects next
EPS expected
$0.74 to $0.83
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $548.9M | $575.8M | $589.2M | $582.8M |
| Cost of what it sold | $262.2M | $226.3M | $265.6M | $223.5M |
| Gross profit | $286.7M | $349.4M | $323.6M | $359.2M |
| What it spent | ||||
| Research and development | $29.7M | $31.4M | $31.5M | $31.7M |
| Sales and admin | $263.6M | $270.4M | $282.8M | $263.7M |
| Other operating costs | -$15.7M | — | -$11.0M | $46.4M |
| Total operating expenses | $277.7M | $301.2M | $303.3M | $341.8M |
| What was left | ||||
| Operating profit | $9.0M | $48.3M | $20.3M | $17.4M |
| Interest on debt | $20.8M | $7.5M | $19.2M | $8.0M |
| Profit before tax | -$566.9M | -$509.5M | $634.0K | $7.5M |
| Tax | $4.0M | $9.3M | $9.0M | $8.5M |
| Net profit | -$571.1M | -$520.6M | -$8.8M | -$1.2M |
| EBITDA | -$471.7M | -$425.0M | $93.2M | $86.6M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Enovis stock hits 52-week low at 19.12 USD By Investing.com
BearishSep 3Enovis inks eCential takeover to develop surgical ortho robots
NeutralSep 2Citizens lowers Enovis stock price target on robotics acquisition
Leans bearishSep 2Enovis to acquire eCential Robotics for up to €190 million
BullishSep 1Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
Leans bullishSep 1Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
Leans bullishSep 1Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
NeutralAug 31William Blair Maintains Enovis Corp(ENOV.US) With Buy Rating
BullishAug 25
Macro
11 macro signals shaping ENOV right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results